title: The treatment of Graves' disease in children.
abstract: Graves' disease is the most common form of hyperthyroidism in childhood. Current treatment options include antithyroid medications, surgery, and radioactive iodine. Medical therapy is generally associated with long-term remission rates of less than 25% and a small risk of serious adverse reactions that include hepatic failure and bone marrow suppression. Total thyroidectomy is associated with very high cure rates and a small risk of hypoparathyroidism and recurrent laryngeal nerve damage. When radioactive iodine is used at appropriate doses, there is a very high cure rate without increased risks of thyroid cancer or genetic damage. Clinicians caring for the child or adolescent with Graves' disease are thus faced with using medications with potential short-term and long-term toxicity, for a condition in which spontaneous remission occurs in the minority of pediatric patients. Definitive therapy in the form of surgery or radioactive iodine is necessary and unavoidable for the majority of pediatric patients with Graves' disease.
authors.affiliation: Yale Pediatric Thyroid Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA. Scott.Rivkees@Yale.edu
authors.forename: Scott A
authors.initials: SA
authors.lastname: Rivkees
mesh_terms: D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D006111:Graves Disease / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000628:therapy; D007457:Iodine Radioisotopes / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology; D013965:Thyroidectomy; D016896:Treatment Outcome
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes